AbbVie sees no need for major acquisitions-CFO
SAN FRANCISCO, Jan 8 (Reuters) - AbbVie Inc, the pharmaceutical company spun off by Abbott Laboratories, is unlikely to use its $7 billion cash balance for a large acquisition, the company's chief financial officer said on Tuesday.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here